Accreditation Information

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Section of Endocrinology, Diabetes and Nutrition at Boston University School of Medicine.  Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Needs Statement

Clinicians need current information explaining the natural course of low risk thyroid cancer and the various treatment options available to  patients. Clinicians need updated information about new medications, including immunotherapy for cancer, which can affect thyroid function tests. Clinicians would benefit from implementing effective screening protocols to detect thyroid function abnormalities in their patients who are at higher risk of developing difficulties.



1. Identify patients who are at higher risk for developing thyroid function test abnormalities due to medications and monitor at appropriate intervals for the development of these abnormalities and reduce the rate of these patients developing unrecognized and untreated thyroid function abnormalities

2. Discuss treatment options available for low risk thyroid cancer with patients based on available scientific data

3. Evaluate the use of a multi-disciplinary team based approach in the care of patients with thyroid cancer


Target Audience

Specialty physicians, Physician assistants, Nurse practitioners, and Nurses interested in endocrinology and thyroid pathology and surgery.


Faculty Disclosure

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.